Results 251 to 260 of about 399,116 (301)

Exosomal miRNA-720 as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma. [PDF]

Korean J Intern Med
Kim JM, Kim HS, Kim JS, Han JW, Lee SK, Nam H, Sung PS, Bae SH, Choi JY, Yoon SK, Jang JW.   +10 more
europepmc   +1 more source

Circulating Interleukin-6 as a Prognostic Biomarker for Mortality in Melioidosis: A Systematic Review and Meta-Analysis. [PDF]

Diseases
Khemla S, Chanthot C, Chittamma A, Thanasai J, Phongphithakchai A, Chatatikun M, Tangpong J, Laklaeng SN, Klangbud WK.   +8 more
europepmc   +1 more source

Prognostic biomarkers in ovarian cancer [PDF]

Cancer Biomarkers, 2011
Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy despite several~decades of progress in diagnosis and treatment. Taking advantage of the robust development of discovery and utility of prognostic biomarkers, clinicians and researchers are developing personalized and targeted treatment strategies.
Jie, Huang, Wei, Hu, Anil K, Sood
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Prognostic biomarkers in malignant lymphomas

Leukemia & Lymphoma, 2010
There has recently been a rapid expansion in research aimed at identifying biomarkers that could improve the prognosis for patients with various subtypes of malignant lymphoma. Genomic and genetic studies have led to the identification of biological and clinical subgroups of diffuse large B-cell lymphomas with distinct underlying molecular features ...
Gascoyne, Randy D., Rosenwald, Andreas, Poppema, Sibrand, Lenz, Georg   +3 more
openaire   +3 more sources

Prognostic Biomarkers for Hodgkin Lymphoma

Pediatric Hematology and Oncology, 2015
The prognosis of patients with classical Hodgkin lymphoma following chemo- and radiotherapy has been excellent during the last 4 decades. However, the development of secondary malignancies is of major concern. Therefore, the reduction of radiotherapy application is a major objective of ongoing clinical trials.
Martin S, Staege, Stefanie, Kewitz, Toralf, Bernig, Caspar, Kühnöl, Christine, Mauz-Körholz   +4 more
openaire   +2 more sources

Prognostic biomarkers in thyroid cancer

Virchows Archiv, 2014
Thyroid carcinomas represent a challenging problem from the prognostic standpoint. Despite an overall good prognosis of the most frequent endocrine malignancy, 10-15 % of papillary thyroid carcinomas (PTCs) turn refractory to radioactive iodine therapy. The increased incidence of thyroid cancer has led to the search for solid prognostic biomarkers that
Paula, Soares, Ricardo, Celestino, Miguel, Melo, Elsa, Fonseca, Manuel, Sobrinho-Simões   +4 more
openaire   +2 more sources

Novel Prognostic Biomarkers in Colorectal Cancer

Digestive Diseases, 2012
The main predictor of outcome of patients with colorectal cancer (CRC) remains the TNM staging system. Biomarkers, i.e. biological indicators of disease progression or of responsiveness to a pharmacological intervention, are expected to be of help in the management of CRC.
A. Malesci, L. Laghi
openaire   +2 more sources

Tumour biomarkers: diagnostic, prognostic, and predictive:

BMJ, 2015
A 63 year old woman presented with a one month history of difficulty speaking and imbalance. She had been diagnosed with breast cancer two years earlier and had been treated with surgery, chemotherapy, and radiotherapy. This was followed by a year of trastuzumab (Herceptin) and continuous tamoxifen treatment.
Shaw, Abigail, Bradley, Marcus D, Elyan, Sean, Kurian, Kathreena M   +3 more
openaire   +2 more sources

A prognostic biomarker of corneal repair

Nature Biomedical Engineering, 2019
A non-invasive biomarker of the degree of collective order of monolayers of corneal endothelial cells cultured for transplantation predicts the long-term prognosis of corneal restoration in patients.
Jodhbir S, Mehta, Viridiana, Kocaba, Gary S, Peh   +2 more
openaire   +2 more sources